Roberta Fenoglio Martina Marchisio Alessandra Baffa Giacomo Quattrocchio Dario Roccatello
10.1007/s40620-022-01402-0
J Nephrol
2023 Jan;36(1):229-232.
anti sars-cov-2-vaccination caplacizumab microangiopathic hemolytic anemia plasma filtration
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/36057036/
Anemia, Hemolytic / therapy COVID-19 / therapy Purpura, Thrombotic Thrombocytopenic / chemically induced Purpura, Thrombotic Thrombocytopenic / diagnosis
Anemia, Hemolytic / therapy COVID-19 / therapy Purpura, Thrombotic Thrombocytopenic / chemically induced Purpura, Thrombotic Thrombocytopenic / diagnosis Case Reports BNT162 Vaccine Humans Male Middle Aged Plasma Exchange BNT162 Vaccine Thrombotic thrombocytopenic purpura, acquired
PMC9440330
36057036
Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
2023